Rama Padmanabhan

Rama Padmanabhan focuses on all types of public and private M&A with a proven track record leading cross-border transactions. A trailblazer in life sciences, she represents biotech, pharmaceuticals and medical device companies in high-stakes transactions while also advising tech clients from a range of industries, from artificial intelligence and healthcare IT to semiconductor, software, ecommerce, consumer and retail.

She is sought out by companies, boards and special committees for counsel on a variety of corporate and securities matters. Besides advising clients through the full spectrum of M&A, Rama has guided clients through venture capital financings, securities offerings and other complex transactions, representing an aggregate value of more than $100 billion.

Chambers-ranked for Corporate/M&A, Rama was named Dealmaker of the Year in Healthcare, Pharma & Biotech at The Deal’s 2020 Middle Market Awards and has been recognized by Lawdragon as one of the 500 Leading Dealmakers in America every year since 2021.